Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00591617 · ClinicalTrials.gov registry record · NA
Optimizing Outcomes Using Suboxone for Opiate Dependence
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 202
- Enrollment target
NCT00591617 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 202 participants.
The verdict
NCT00591617, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 202 participants
- Enrollment target
Study Summary
Building on a platform of pharmacological treatment with Suboxone (buprenorphine and naloxone), participants are randomly assigned to one of four psychosocial treatment conditions.
Interventions
- OTHER Psychosocial treatment plus Suboxone pharmacotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2006-09 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00591617
The ClinicalTrials.gov registry entry for NCT00591617 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 202 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Psychosocial treatment plus Suboxone pharmacotherapy is the first listed.
NCT00591617 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00591617 about?
NCT00591617 is a clinical study titled "Optimizing Outcomes Using Suboxone for Opiate Dependence". Building on a platform of pharmacological treatment with Suboxone (buprenorphine and naloxone), participants are randomly assigned to one of four psychosocial treatment conditions.
What is the current status of trial NCT00591617?
This trial is currently completed. It is a NA study. The enrollment target is 202 participants. The study started on 2006-09. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00591617?
The interventions under investigation include: Psychosocial treatment plus Suboxone pharmacotherapy (OTHER).
Who is sponsoring clinical trial NCT00591617?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.